Aminophylline for bradyasystolic cardiac arrest in adults

Katrina F. Hurley, Kirk Magee, Robert Green

Producción científica: Contribución a una revistaArtículo de revisiónrevisión exhaustiva

6 Citas (Scopus)

Resumen

Background: In cardiac ischaemia, the accumulation of adenosine may lead to or exacerbate bradyasystole and diminish the effectiveness of catecholamines administered during resuscitation. Aminophylline is a competitive adenosine antagonist. Case studies suggest that aminophylline may be effective for atropine-resistant bradyasystolic arrest. Objectives: To determine the effects of aminophylline in the treatment of patients in bradyasystolic cardiac arrest, primarily survival to hospital discharge. We also considered survival to admission, return of spontaneous circulation, neurological outcomes and adverse events. Search methods: For this updated review, we searched the Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE, CINAHL, LILACS, ClinicalTrials.gov and WHO International Clinical Trials Registry Platform in November 2014. We checked the reference lists of retrieved articles, reviewed conference proceedings, contacted experts and searched further using Google. Selection criteria: All randomised controlled trials comparing intravenous aminophylline with administered placebo in adults with non-traumatic, normothermic bradyasystolic cardiac arrest who were treated with standard advanced cardiac life support (ACLS). Data collection and analysis: Two review authors independently reviewed the studies and extracted the included data. We contacted study authors when needed. Pooled risk ratio (RR) was estimated for each study outcome. Subgroup analysis was predefined according to the timing of aminophylline administration. Main results: We included five trials in this analysis, all of which were performed in the prehospital setting. The risk of bias was low in four of these studies (n = 1186). The trials accumulated 1254 participants. Aminophylline was found to have no effect on survival to hospital discharge (risk ratio (RR) 0.58, 95% confidence interval (CI) 0.12 to 2.74) or on secondary survival outcome (survival to hospital admission: RR 0.92, 95% CI 0.61 to 1.39; return of spontaneous circulation: RR 1.15, 95% CI 0.89 to 1.49). Survival was rare (6/1254), making data about neurological outcomes and adverse events quite limited. The planned subgroup analysis for early administration of aminophylline included 37 participants. No one in the subgroup survived to hospital discharge. Authors' conclusions: The prehospital administration of aminophylline in bradyasystolic arrest is not associated with improved return of circulation, survival to admission or survival to hospital discharge. The benefits of aminophylline administered early in resuscitative efforts are not known.

Idioma originalEnglish
Número de artículoCD006781
PublicaciónCochrane Database of Systematic Reviews
Volumen2015
N.º11
DOI
EstadoPublished - nov. 23 2015

Nota bibliográfica

Funding Information:
Cummins RO, Chamberlain DA, Abramson NS, Allen M, Baskett P, Becker L, et al. Recommended guidelines for uniform reporting of data from out-of-hospital cardiac arrest: the Utstein Style. Task Force of the American Heart Association, the European Resuscitation Council, the Heart and Stroke Foundation of Canada, and the Australian Resuscitation Council. Annals of Emergency Medicine 1991; 20(8):861–74.

Funding Information:
Jacobs I, Nadkarni V, Bahr J, Berg RA, Billi JE, Bossaert L, et al. Cardiac arrest and cardiopulmonary resuscitation outcome reports: update and simplification of the Utstein templates for resuscitation registries. A statement for healthcare professionals from a task force of the international liaison committee on resuscitation (American Heart Association, European Resuscitation Council, Australian Resuscitation Council, New Zealand Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Southern Africa). Resuscitation 2004;63(3):233–49. [MEDLINE: PMID: 15582757]

Funding Information:
We carried out a comprehensive search to identify relevant trials, irrespective of language and publication status. We initially searched the Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library (Issue 4, 2009), MEDLINE, EMBASE, CINAHL and LILACS on 26 November 2009 (Appendix 1; Hurley 2007; Hurley 2013). We performed new searches of CENTRAL, MEDLINE, EMBASE and CINAHL in November 2014 (Appendix 2). We also searched ClinicalTrials.gov (www.clinicaltrials.gov) and the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP; http://apps.who.int/trialsearch/), using the terms ’cardiac arrest’ OR ’asystole’ OR ’bradyasystole’ as the condition and ’aminophylline’ OR ’adenosine antagonist’ as the intervention. We used similar terms to search the grey literature through Google Scholar, the Canada Institute for Scientific and Technical Information (CISTI) Catalogue and the British Library Public Catalogue. We reviewed reference lists of all available primary studies and review articles to identify potentially relevant citations. We also contacted authors of primary studies to inquire about other published or unpublished trials known to them. We contacted scientific advisors for the pharmaceutical companies that manufacture aminophylline (Omega Laboratories and Hospira Healthcare Corporation) for any unpublished results on the use of aminophylline in asystolic arrest. Finally, we reviewed reference lists of relevant trials and review articles as well as conference proceedings from the Canadian Association of Emergency Physicians, the American College of Emergency Physicians, the Society for Academic Emergency Medicine and the American Heart Association (January 1997 to December 2012) and from the European Society of Cardiology (January 2005 to December 2012).

Publisher Copyright:
© 2015 The Cochrane Collaboration.

ASJC Scopus Subject Areas

  • Pharmacology (medical)

PubMed: MeSH publication types

  • Journal Article
  • Meta-Analysis
  • Research Support, Non-U.S. Gov't
  • Review
  • Systematic Review

Huella

Profundice en los temas de investigación de 'Aminophylline for bradyasystolic cardiac arrest in adults'. En conjunto forman una huella única.

Citar esto